Study of Serum Ghrelin Level in Patients With Diabetes Mellitus Type 2: In Relation With Insulin Level

Ghrelin is an orexigenic hormone. It has a suppressive effect on insulin release from pancreatic islets. In T2DM patients, hyperinsulinemia, lower ghrelin levels are observed. Total ghrelin levels in fasting plasma were lower in T2DM patients than in nondiabetic patients. It was aimed to consider serum ghrelin windows in the T2DM patient and control. It was observed that ghrelin diabetes experiments in general patient groups were estimated to be lower (262.37129.29pg/mL), (487.4053.81pg/mL) compared to the control group (p<0.001). Patient group insulin (27.3911.06U/mL) and control settings (12.075.49U/mL) (p<0.001). It also shows high yield positive rates with ghrelin and insulin history (p<0.001, r=-0.699). Significantly improved performance with serum ghrelin and insulin, culprit glucose and HbA1C. A significant relationship between ghrelin and insulin and T2DM has been investigated in this comprehensive context, and there is a content relationship between ghrelin and insulin.